Impact BioMedical Inc. (IBO)

NYSEAMERICAN: IBO · Real-Time Price · USD

0.4493

+0.0161 (3.72%)

At close: Aug 20, 2026, 4:00 PM EDT

0.4493

0.00 (0.00%)

After-hours: Aug 20, 2026, 6:30 PM EDT

Impact BioMedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.01	0	2	0	0	0.05
Cash & Short-Term Investments	0.01	0	2	0	0	0.05
Cash Growth	-98.40%	-99.85%	199800.00%	-50.00%	-95.65%	-36.42%
Accounts Receivable	-	0.01	-	-	-	-
Other Receivables	-	-	-	0.13	-	-
Receivables	0.2	0.2	0.18	0.33	0.02	0.2
Inventory	0.06	0.06	-	-	-	-
Prepaid Expenses	0.05	0.14	0.26	-	0.06	0
Other Current Assets	-	0	0	-	0.04	0.04
Total Current Assets	0.32	0.41	2.45	0.33	0.12	0.29
Property, Plant & Equipment	-	-	0.02	0.29	0.28	-
Long-Term Investments	-	-	-	-	0.78	4.82
Goodwill	-	-	-	25.09	25.09	25.09
Other Intangible Assets	16.43	16.99	17.81	18.92	20.03	21.15
Total Assets	16.75	17.41	20.29	44.63	46.5	56.43

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.47	0.35	0.31	0.83	0.54	0.12
Accrued Expenses	0.25	0.19	0.19	0.23	0.06	0.01
Short-Term Debt	-	-	8.88	12.07	9.99	12.52
Other Current Liabilities	1.33	0.62	0.4	-	-	-
Total Current Liabilities	2.05	1.16	9.79	13.14	10.59	12.65
Long-Term Deferred Tax Liabilities	0.69	0.69	3.27	3.24	3.24	3.86
Total Liabilities	2.73	1.85	13.05	16.37	13.83	16.5

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.11	0.11	0.01	0.01	0.07	0.13
Additional Paid-In Capital	63.15	62.01	41.86	38.11	38.11	38.06
Retained Earnings	-52.49	-49.51	-37.67	-12.96	-8.63	-1.57
Total Common Equity	10.77	12.61	4.2	25.16	29.56	36.61
Minority Interest	3.25	2.95	2.98	3.04	3.11	3.32
Shareholders' Equity	14.01	15.56	7.24	28.26	32.67	39.92
Total Liabilities & Equity	16.75	17.41	20.29	44.63	46.5	56.43

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	8.88	12.07	9.99	12.52
Net Cash (Debt)	0.01	0	-6.88	-12.07	-9.99	-12.48
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.00	0.00	-0.64	-0.20	-0.14	-0.18
Filing Date Shares Outstanding	107.82	107.82	12.09	10	70.5	70.5
Total Common Shares Outstanding	107.82	104.62	11.5	10	70.5	70.5
Working Capital	-1.73	-0.75	-7.34	-12.8	-10.47	-12.36
Book Value Per Share	0.10	0.12	0.37	2.52	0.42	0.52
Tangible Book Value	-5.66	-4.39	-13.61	-18.85	-15.57	-9.63
Tangible Book Value Per Share	-0.05	-0.04	-1.18	-1.89	-0.22	-0.14
Machinery	-	-	0.03	-	0.03	-
Construction In Progress	-	-	-	-	0.25	-

SEC Filings: 10-K · 10-Q